PharmaBlock Sciences Nanjing Inc
SZSE:300725
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PharmaBlock Sciences Nanjing Inc's stock price target?
Not Available
PharmaBlock Sciences Nanjing Inc doesn't have any price targets made by Wall Street professionals.
What is PharmaBlock Sciences Nanjing Inc's Revenue forecast?
Projected CAGR
20%
For the last 9 years the
compound annual growth rate for
PharmaBlock Sciences Nanjing Inc's revenue is
32%.
The projected
CAGR
for the next 3 years is
20%.
What is PharmaBlock Sciences Nanjing Inc's Operating Income forecast?
Projected CAGR
29%
For the last 9 years the
compound annual growth rate for
PharmaBlock Sciences Nanjing Inc's operating income is
30%.
The projected
CAGR
for the next 2 years is
29%.
What is PharmaBlock Sciences Nanjing Inc's Net Income forecast?
Projected CAGR
19%
For the last 9 years the
compound annual growth rate for
PharmaBlock Sciences Nanjing Inc's net income is
31%.
The projected
CAGR
for the next 3 years is
19%.
